293 related articles for article (PubMed ID: 27139498)
1. Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.
Shim SR; Cho YJ; Shin IS; Kim JH
Int Urol Nephrol; 2016 Aug; 48(8):1215-1227. PubMed ID: 27139498
[TBL] [Abstract][Full Text] [Related]
2. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
3. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis.
Di XP; Luo DY; Jin X; Zhao WY; Li H; Wang KJ
Int Urogynecol J; 2021 May; 32(5):1129-1141. PubMed ID: 33638677
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis.
Giannantoni A; Gubbiotti M; Bini V
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31480323
[TBL] [Abstract][Full Text] [Related]
7. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Kuo YC; Kuo HC
Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
[TBL] [Abstract][Full Text] [Related]
8. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
9. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
10. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
11. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Lee CL; Kuo HC
Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
[TBL] [Abstract][Full Text] [Related]
13. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
[TBL] [Abstract][Full Text] [Related]
15. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
Pyo JS; Cho WJ
Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
[TBL] [Abstract][Full Text] [Related]
18. Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.
Jhang JF
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31689912
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
Jhang JF; Jiang YH; Kuo HC
Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
